Global Real World Evidence Analytics Market

Real World Evidence Analytics Market Size, Share, Growth Analysis, By End user(Pharmaceutical, Biotechnology, Medical Device Companies, Healthcare Payers), By Application(Market Access & Reimbursement, Drug Development & Approval, Post Market Surveillance, Medical Device Development), By Therapeutic Area(Oncology, Cardiovascular, Neurology, Immunology), By Region - Industry Forecast 2024-2031


Report ID: SQSG35G2031 | Region: Global | Published Date: April, 2024
Pages: 157 | Tables: 95 | Figures: 76

Real World Evidence Analytics Market Regional Insights

North America dominated the market in 2021. Some of the key factors anticipated to propel the growth of this market include the rising prevalence of chronic diseases in the elderly population, a move toward value-based care, an increase in personalised healthcare, the availability of electronic datasets, a well-established healthcare industry, and the growth of big data in the healthcare sector.

Asia Pacific is fastest growing region during the forecast period. Owing to the rising government initiatives for the adoption of RWE studies and the presence of many contract research and manufacturing organizations in countries, such as China and India. Rising demand for better healthcare services is also estimated to fuel the market growth.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Real World Evidence Analytics Market size was valued at USD 2.26 billion in 2019 and is poised to grow from USD 2.45 billion in 2023 to USD 4.97 billion by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031).

Global Real World Evidence Analytics Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'IQVIA Inc.', 'Optum, Inc.', 'IBM Corporation', 'Parexel International Corporation', 'Cognizant Technology Solutions Corporation', 'Oracle Corporation', 'Clinigen Group PLC', 'SAS Institute Inc.', 'PPD, Inc.', 'Syneos Health, Inc.', 'Anthem, Inc.', 'Change Healthcare Inc.', 'Pharmaceutical Product Development, LLC (PPD)', 'Evidera, Inc.', 'ICON plc', 'Flatiron Health, Inc.', 'HealthVerity, Inc.', 'PAREXEL International Corporation', 'Phesi Inc.', 'Aetion, Inc.'

Rising Geriatric Population to Drive Market Growth

Introduction of AI to Surge Market Growth

North America dominated the market in 2021. Some of the key factors anticipated to propel the growth of this market include the rising prevalence of chronic diseases in the elderly population, a move toward value-based care, an increase in personalised healthcare, the availability of electronic datasets, a well-established healthcare industry, and the growth of big data in the healthcare sector.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Real World Evidence Analytics Market

Report ID: SQSG35G2031

$5,300
BUY NOW GET FREE SAMPLE